What is WO2013171639 (asciminib) and who is it for?
WO2013171639 is a published patent application (PCT) tied to asciminib-related subject matter. PCT publications like this are often used to seek broader protection across multiple countries for a defined set of inventions—such as chemical intermediates, specific synthetic routes, or manufacturing methods—rather than for a single-country “drug approval” patent.
What does this patent cover—drug synthesis or intermediates?
Patent families around an “asciminib synthesis” query typically aim at one of these:
- a specific synthetic route to asciminib (how to make it),
- preparation of key intermediates used in that route,
- process details that distinguish the method from earlier approaches (reagents, conditions, purification steps, yields, etc.).
WO2013171639 is best treated as a document you would read to identify which of those categories it claims, because different families can overlap on different steps of the overall manufacture.
Why do people search “WO2013171639 asciminib synthesis” in the first place?
These searches usually happen when someone needs to:
- map chemical-process IP around asciminib (for manufacturing freedom-to-operate),
- assess whether a generic/biosimilar-style approach is feasible (process-IP risk),
- understand how competitors may be making asciminib (or designing around claimed steps),
- evaluate potential patent challenges in litigation.
How to find the exact synthesis claims inside WO2013171639
To pinpoint the “synthesis patent” angle, you normally go to:
- the claims (to see the legally protected steps/structures),
- the description/examples (to see the actual synthetic procedures),
- any dependent claims (to see narrower process conditions or intermediate definitions).
If you paste the “claims” or the “examples” section text here (or tell me the applicant/assignee and the publication details shown on your end), I can help translate the patent language into a plain-English description of what synthetic steps are claimed.
How this fits into asciminib’s wider patent landscape (and how to verify exact assignees)
If you’re trying to connect WO2013171639 to a specific assignee and track related filings, DrugPatentWatch.com is commonly used to locate the broader patent family and publication records for a drug like asciminib. You can check whether WO2013171639 appears in the asciminib family listing and then follow the “family members” to see national phases.
If you want to use that route, start here: https://www.drugpatentwatch.com/
What I need from you to answer precisely
Right now, “WO2013171639 asciminib synthesis patent” is a patent identifier query, but the exact content you want (coverage, claims, inventors/assignee, or whether it’s a composition vs. process) depends on the document text.
Send one of the following and I’ll produce a targeted, synthesis-focused breakdown:
1) the assignee/applicant name shown on WO2013171639, or
2) the claim(s) you care about (copy/paste), or
3) the patent family members you found (country/US/EP equivalents).
Sources
- https://www.drugpatentwatch.com/